- Conditions
- Persistent Atrial Fibrillation
- Interventions
- The Estech COBRA® Surgical System
- Device
- Lead sponsor
- Endoscopic Technologies, Inc
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 13
- States / cities
- Mesa, Arizona • Hartford, Connecticut • Atlanta, Georgia + 10 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 128
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- PVAI followed by adenosine provocation
- Procedure
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 188 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2020
- U.S. locations
- 2
- States / cities
- Austin, Texas
- Conditions
- Obstructive Sleep Apnea (OSA), Atrial Fibrillation (Paroxysmal), Palpitations
- Interventions
- Rhythm Express Wearable System
- Device
- Lead sponsor
- VivaQuant
- Industry
- Eligibility
- 21 Years to 85 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 4
- States / cities
- Conway, Arkansas • St Louis, Missouri • Charlotte, North Carolina + 1 more
- Conditions
- Atrial Fibrillation, Paroxysmal Arrhythmia
- Interventions
- Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)
- Device
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 511 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2014
- U.S. locations
- 45
- States / cities
- Huntsville, Alabama • Anchorage, Alaska • Phoenix, Arizona + 40 more
- Conditions
- Atrial Fibrillation
- Interventions
- Pulsed Field Ablation
- Device
- Lead sponsor
- Heart Rhythm Clinical and Research Solutions, LLC
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 35
- States / cities
- Birmingham, Alabama • Jonesboro, Arkansas • San Francisco, California + 31 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- BMS-919373, Placebo (Matching with BMS-919373)
- Drug
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Eligibility
- Not listed
- Enrollment
- 158 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 20
- States / cities
- Anaheim, California • Costa Mesa, California • Long Beach, California + 15 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Synaptic Cryoablation System
- Device
- Lead sponsor
- Synaptic Medical Corporation
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 128 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 10
- States / cities
- Phoenix, Arizona • Jonesboro, Arkansas • Los Angeles, California + 6 more
- Conditions
- Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- MFAM
- Device
- Lead sponsor
- Vivek Reddy
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Treatment with IntellaNav StablePoint Ablation Catheter
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 321 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 25
- States / cities
- Jonesboro, Arkansas • Orlando, Florida • Sarasota, Florida + 22 more
- Conditions
- Atrial Fibrillation
- Interventions
- Antiarrhythmic drug, Catheter ablation
- Drug · Procedure
- Lead sponsor
- Valley Health System
- Other
- Eligibility
- Not listed
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Ridgewood, New Jersey
- Conditions
- Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Interventions
- OPC-108459, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 9
- States / cities
- Washington D.C., District of Columbia • Hollywood, Florida • Jacksonville, Florida + 6 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Ablation
- Device
- Lead sponsor
- Hansen Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 150 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 9
- States / cities
- Mesa, Arizona • Rochester, Minnesota • Englewood, New Jersey + 6 more
- Conditions
- Atrial Fibrillation
- Interventions
- OMNYPULSE™ Catheter with the TRUPULSE Generator
- Device
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 440 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 43
- States / cities
- Phoenix, Arizona • Burlingame, California • La Jolla, California + 34 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Self- Report Evaluation-Duke Activity Status Index, Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire, Cardiopulmonary exercise test (CPET), Transthoracic echocardiogram, Ambulatory cardiac rhythm assessment, Cardiovascular magnetic resonance (CMR)
- Behavioral · Diagnostic Test
- Lead sponsor
- Virginia Commonwealth University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Radiofrequency ablation, antiarrhythmic drugs, Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs, ThermoCool Radiofrequency Catheter
- Device · Drug
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2006
- U.S. locations
- 3
- States / cities
- Birmingham, Alabama • Boston, Massachusetts • Columbus, Ohio
- Conditions
- Atrial Fibrillation
- Interventions
- Inflammatory biomarkers
- Other
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Paroxysmal Atrial Fibrillation, Atrial Fibrillation
- Interventions
- DiamondTemp Ablation catheter, TactiCath Quartz Ablation catheter
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 482 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Los Angeles, California • Redwood City, California + 8 more
- Conditions
- Paroxysmal Atrial Fibrillation, Atrial Arrhythmia
- Interventions
- Circumferential Pulmonary Vein Ablation, Segmental Pulmonary Vein Isolation
- Procedure
- Lead sponsor
- University of California, San Diego
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 97 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2021
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Arctic Front™ Cardiac Cryoablation Catheter
- Device
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2028
- U.S. locations
- 13
- States / cities
- Anchorage, Alaska • Stamford, Connecticut • Washington D.C., District of Columbia + 10 more
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Catheter ablation to treat paroxysmal atrial fibrillation
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Atrial Fibrillation
- Interventions
- CFAE ablation
- Procedure
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 86 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 2
- States / cities
- Maywood, Illinois • Baltimore, Maryland
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- TactiCath Quartz treatment
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 178 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 20
- States / cities
- Glendale, California • Sacramento, California • Atlanta, Georgia + 16 more
- Conditions
- Fibrillation, Atrial
- Interventions
- omega-3-acid ethyl esters, Placebo
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 663 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 178
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Anchorage, Alaska + 149 more
- Conditions
- Atrial Fibrillation, Paroxysmal AF
- Interventions
- Catheter Ablation
- Device
- Lead sponsor
- Biosense Webster, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 234 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2013
- U.S. locations
- 26
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona • Santa Barbara, California + 23 more